Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

This bill authorizes the Secretary of Health and Human Services (HHS) to establish programs aimed at improving the early detection and intervention of uterine fibroids. A key component involves HHS conducting or supporting research to identify and formulate evidence-based strategies for increasing early detection in healthcare settings, which will then be made available for implementation by grantees. The legislation empowers the Secretary to award grants to States to carry out programs focused on increasing early detection and intervention for uterine fibroids, alongside developing public awareness and education campaigns. Grant funds can support activities like advanced gynecological imaging, patient navigation, implementing proven early detection strategies, and facilitating healthcare access, with priority given to States serving socially vulnerable populations at elevated risk. Additionally, the bill authorizes grants for further research, including clinical trials, into specific areas such as disparities in pain control and management for uterine fibroid surgical treatment, and other intrauterine conditions. The Act mandates regular reports to Congress every two years, summarizing grant program outcomes and outlining research developments.